Douglas Pippin
Principal investigator, leads Praeventix, LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.9MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $3.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2023 | NIH | SBIR Phase II In Vivo Characterization of 5-HT7 Modulators in Rat Models of Cocaine Use Disorder | $1.3M | Praeventix, LLC |
| Aug 1, 2018 | NIH | SBIR Phase II Novel 5-HT7 Antagonists for the treatment of inflammatory bowel disease | $2.5M | Praeventix, LLC |
| Aug 10, 2017 | NIH | SBIR Phase I Novel HT Antagonists for the treatment of inflammatory bowel disease | $232K | Praeventix, LLC |
Peer ranks
Federal funding#405
Awards as PI#822
Patents#273
Companies
- Praeventix, LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.